We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.30 | 1.20 | 1.40 | 1.30 | 1.30 | 1.30 | 27,450 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.71 | 1.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2018 13:53 | I have over 2.625% now. I think we should set up a PYC Major Private Shareholder group at some point. If we can get together 5% we can approach PYC management about 'upgrading their brokers'. At 10% we could call an EGM demanding it. It's either grossly incompetent or negligent on the part of the Brokers to not mention comparitors like Certara Deepmind And GRAIL | the stigologist | |
30/4/2018 13:35 | Should reach 10p in the coming days.Nai.dyoretc. | miahkaysor | |
30/4/2018 13:33 | Just filled ;-) | miahkaysor | |
30/4/2018 13:33 | I have sent a Buy order for 73k @ 6.50p but not filled yet.Fingers crossed.Nai.dyor | miahkaysor | |
30/4/2018 13:16 | Another great Technical sign shareholder base is improving in quality | the stigologist | |
30/4/2018 13:08 | Lovely chart... Note this is the long term weekly chart so it points out long term trends very well as it's based on long term moving averages (i.e. the collective wisdom of the market) not short term trading by ignorant traders Clear to see there is a definite change in the trend AND highly significant break out above long term moving averages after consolidation of the original 1p to 32p breakout move | the stigologist | |
30/4/2018 13:05 | When even the House Broker is so ignorant and behind the curve that they do not mention likes of Certara, DeepMind, GRAIL inc (Multi-billion dollar concerns targeting the same markets as Physiomics but where Physiomics have a very strong position in specific markets as evidenced by their leading edge Academic studies/collaboratio | the stigologist | |
30/4/2018 13:00 | Slowly but surely the market will wake up to PYC 6p is the new 1p We saw with the 28th November RNS that even 'old news' can see this go from 1p to 32p within 48 hours So I'm fully expecting a shoot out of nowhere from 6p into 50-100p range on the basis of an upcoming RNS As I've highlighted previously there are numerous RNSes due which will cause serious re-evaluation of this stock | the stigologist | |
30/4/2018 12:00 | I hope we get a 1m grant. Although that company receiving 1m reduces our chances a little | spacedust | |
30/4/2018 09:22 | Companies are starting to announce funding from Biomedical Catalyst latest funding round CAMBRIDGE, England, April 27, 2018 /PRNewswire/ -- Grant award funds expanded operations and recognizes innovative drug discovery programme PhoreMost Limited and NeoPhore Limited today announced the companies will receive £1.0 million of funding following award of a Biomedical Catalyst grant in a recent Innovate UK competition. The companies are partners on a grant titled, "A novel small molecule approach to enhance cancer immunotherapy." Their research plan proposes to develop small-molecule drugs that will stimulate cancer immunity by leveraging well-validated genetic mechanisms. The strategy is central to NeoPhore's approach to spark "dynamic neoantigen evolution" by targeting DNA mismatch repair to induce neoantigen creation in poorly immunogenic tumors. NeoPhore and PhoreMost are both headquartered in Cambridge UK, and NeoPhore was formed as a PhoreMost spin-out following investment of £3 million from Sixth Element Capital. | the stigologist | |
30/4/2018 08:40 | I am expecting Another contract win from last conference in coming days Even if it's worth 50k it will be good | tmmalik | |
29/4/2018 21:09 | "Investors who get in now, when little is priced into the valuation, stand the chance of making a return multiples of the current share price" | the stigologist | |
29/4/2018 21:08 | PYC - Done a mega thread on it on Twitter Expecting some big news and validation over coming weeks so will be a lot of new investors looking to research this Company This twitter thread will be a key starting point as it includes all the best bits of the Hybridan Initiation of Coverage research note from October 2016 | the stigologist | |
29/4/2018 18:18 | It’s now 2.5%. Thought it was 2%. Nearly £150k at current share price. £750k at highest £0.30. Interesting why you post so much! | smcl | |
28/4/2018 22:22 | Stig and I don't get along for some reason. I can see another 100% day in short order but think 200k is too much to throw in here. Already have 1000000 shares so will keep powder dry thank you all for words of advice. All in my opinion | markth126 | |
28/4/2018 21:16 | Report from 2016, not sure if posted before but good insight into pyc direction after Jim Millen taken on. Indicates value of clinical trials could be worth £150K+ compared to value of pre-clinical trials worth £50K. hxxps://www.scribd.c | myamay16 | |
28/4/2018 14:27 | You wouldn't even throw 20k at this. | davevt | |
28/4/2018 11:27 | Why don’t you ask the Stig- he must hold a couple of million. Says he has 2% £120k | smcl | |
28/4/2018 11:11 | Completely agree with this. I am a newbie just learning the ropes but putting 200k into one company is almost suicidal. Do not jump in too quickly, I made that mistake and it's cost me quite a bit this week.Valuable lesson in the longer run though! | coldspring | |
28/4/2018 00:24 | Mark- maybe.... | smcl | |
27/4/2018 23:13 | Wish I had the bottle to lump 200k to throw at this, sold my business and just looking at investing in some good companies. This and ARS are a great bet but at the minute just can't pull the trigger, but have a heavy feeling that in a couple of month I'll be regretting this! 200k to a million is an easy expectation here in my view. | markth126 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions